TP53 and non-small cell lung carcinoma: This intricate relationship gains particular significance in advanced cancers, including Non-Small Cell Lung Cancer (NSCLC), where TP53 gene mutations and HIF-1 activation in hypoxic regions are frequently observed (Amelio et al. 2018).